Nocturnal temperature controlled laminar airflow for treating atopic asthma: a randomised controlled trial

Robert Boyle, Christophe Pedroletti, Magnus Wickman, Leif Bjermer, Erkka Valovirta, Ronald Dahl, Andrea von Berg, Olof Zetterström, John O. Warner

Thorax · 2011 · 70 citations · 22 references

DOIFull text

Open access

Abstract

Inhalant exposure reduction with TLA improves quality of life, airway inflammation and systemic allergy in patients with persistent atopic asthma. TLA may be a treatment option for patients with inadequately controlled persistent atopic asthma. Trial registration number Clinical Trials NCT00986323.

References

22